The book "Integration of Pharmaceutical Discovery and Development" offers a comprehensive analysis of the changes that occurred in the pharmaceutical industry during the early 1990s. It highlights the transition from a highly segmented approach to drug discovery and development to an integrated model that requires close collaboration among various disciplines. The authors Ronald T. Borchardt, Roger M. Freidinger, Tomi K. Sawyer, and Philip L. Smith present case studies that illustrate interdisciplinary interactions and the necessity of a team-oriented approach to drug development. The book is aimed at professionals and scientists seeking a deeper understanding of the complex processes involved in drug development and the associated challenges. It serves as a valuable reference for anyone working in pharmaceutical research and development.